ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Cervix Moves Significantly During Radiation for Cancer

February 27, 2009

New NCI division For Center, Training, Organ Systems, Construction Seen As Likely Prospect

April 17, 1987

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas

February 3, 1984

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976